Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H6N2 |
Molecular Weight | 94.1145 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=CC=C1
InChI
InChIKey=ICSNLGPSRYBMBD-UHFFFAOYSA-N
InChI=1S/C5H6N2/c6-5-3-1-2-4-7-5/h1-4H,(H2,6,7)
Molecular Formula | C5H6N2 |
Molecular Weight | 94.1145 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position. | 2001 Jan 22 |
|
Inhibition of copper amine oxidases by pyridine-derived aldoximes and ketoximes. | 2001 Nov-Dec |
|
Structural analysis of the sugar chains of human urinary thrombomodulin. | 2001 Oct |
|
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structures. | 2001 Oct 31 |
|
Neuronal nicotinic receptor agonists: a multi-approach development of the pharmacophore. | 2001 Sep |
|
Synthesis and structural analysis of the copper(II) complexes of N2-(2-pyridylmethyl)-2-pyridinecarboxamide. | 2001 Sep |
|
Synthesis and anti-HIV activity of some isatin derivatives. | 2001 Sep-Oct |
|
Synthesis of some new quinoline derivatives: new routes to synthesize polysubstituted 2(1H)-quinolone derivatives. | 2001 Sep-Oct |
|
Properties of some alkyl substituted phthalocyanines and related macrocycles. | 2002 |
|
The nature of the receptor site for the reversible K+ channel blocking by aminopyridines. | 2002 Apr 10 |
|
Analysis of fluorogenic Smith degradation products of 7-(1,3-disulfonaphtyl)amino-disaccharides for linkage position analysis of carbohydrates. | 2002 Dec |
|
Syntheses and magnetic properties of hexanuclear [Cp2Mn3(L1)4]2 and octanuclear [Mn8(L2)12(mu 4-O)2] (L1 = 2-HNC5H5N, L2 = 2-NH-3-Br-5-MeC5H3N, Cp = C5H5). | 2002 Dec 21 |
|
An NMR investigation of the conformational equilibria of 2-(2'-pyridyl)ethylphosphonic acid in several solvents. | 2002 Feb-Mar |
|
Analysis of alpha-amylase-derived pyridylamino-dextran sulfate oligomers by the combination of size-exclusion and reversed-phase high-performance liquid chromatography. | 2002 Jan 25 |
|
A convenient synthesis of 2-(alkylamino)pyridines. | 2002 Jul 12 |
|
Potentiometric and spectrofluorimetric studies on complexation of tenoxicam with some metal ions. | 2002 Jun 1 |
|
Novel vanadium(V) compounds with a layer structure: synthesis, crystal structures, and solid state NMR spectroscopy of [(VO(2))(2)(4,4'-bpy)(0.5)(4,4'-Hbpy)(XO(4))] x H(2)O (X = P and As). | 2002 Jun 3 |
|
2-Aminopyridinium-succinate-succinic acid (2/1/1). | 2002 Nov |
|
Antitumor agents. 2. Synthesis, structure-activity relationships, and biological evaluation of substituted 5H-pyridophenoxazin-5-ones with potent antiproliferative activity. | 2002 Nov 21 |
|
X-ray diffraction and (1)H NMR in solution: structural determination of lanthanide complexes of a Py(2)N(6)Ac(4) ligand. | 2002 Oct 7 |
|
N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. | 2002 Sep |
|
Distance dependence of electron transfer across peptides with different secondary structures: the role of Peptide energetics and electronic coupling. | 2003 Apr 2 |
|
Structural modulation of Cu(I) and Cu(II) complexes of sterically hindered tripyridine ligands by the bridgehead alkyl groups. | 2003 Feb 24 |
|
2-aminopyridinium benzoate. | 2003 Jan |
|
Selective complex formation of some chromogenic calix[4]arene derivatives detected by Fourier transform infrared spectroscopy 1. Solution experiments. | 2003 Jan 1 |
|
NMR evaluation of the configurational stability of Cu(I) complexes. | 2003 Jan 27 |
|
Could redox-switched binding of a redox-active ligand to a copper(II) centre drive a conformational proton pump gate? A synthetic model study. | 2003 Jan 3 |
|
Structural chemistry and In vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against Mycobacterium smegmatis. | 2003 Jan 6 |
|
Localization of defined carbohydrate epitopes in bovine polysialylated NCAM. | 2003 Jan-Feb |
|
N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system. | 2003 Jul |
|
Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)].EtOH. | 2003 Jun 1 |
|
Plant cultured cells expressing human beta1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. | 2003 Mar |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:20:48 UTC 2023
by
admin
on
Fri Dec 15 17:20:48 UTC 2023
|
Record UNII |
WSX981HEWU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000142926
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
2068
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
m1739
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID0024505
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
504-29-0
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
10439
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
C032439
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
431
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
2-AMINOPYRIDINE
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
207-988-4
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
1544519
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
WSX981HEWU
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY | |||
|
SUB117598
Created by
admin on Fri Dec 15 17:20:48 UTC 2023 , Edited by admin on Fri Dec 15 17:20:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|